Title:

MannKind at JPMorgan Healthcare Conference Transcript

Price:$54.00
Publication Date:Jan 08, 2008
Source:Thomson StreetEvents
Company:MannKind
Report Type:Transcript
Abstract:Final Transcript of MNKD presentation, 8-Jan-08 8:00am PT
Brief Excerpt:... - JP Morgan - AnalystAll right. Good morning. We're going to get started here with the next presentation. I know the slides are pretty low here and there are a few seats left up front. So, any of you want to move up front, better visibility. Anyway, my name is Cory Kasimov. I'm a senior biotech analyst here at JP Morgan. And it's my pleasure to introduce the next company to present to us today. It's MannKind Corporation. MannKind is a biotech company focused on developing products for diseases such as diabetes and cancer. The Company's lead clinical candidate, Technosphere Insulin, or TI, is an inhaled insulin system for the treatment of diabetes. #### should be a pretty important year for MannKind as data from the ongoing Phase III program should begin to emerge, coming up in the second quarter.Here to present for MannKind is Chairman and CEO, Alfred Mann. So, let me turn it over to Al. ...
Word Count:3635
Length:7 Pages
Ticker:MNKD
Time:8:00am PT
Related Report(s):
Format:Adobe Acrobat Adobe Acrobat
Free Sample: Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $54.00




Thomson StreetEvents

Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool. <br/>Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

  about us contact us public company index private company index pcan widget your privacy rights terms & conditions